Science

New study finds antibiotic resistant gene in fresh food samples

Dinesh C Sharma New Delhi | Updated on April 25, 2018 Published on April 25, 2018

Abdul Ghafur of Apollo Cancer Institute, Chennai presenting the study at ECCMID in Madrid

Antibiotic drug resistance is assuming dangerous proportions at global level and India is one of the worst affected countries.

A new study in India has found bacteria resistant to the most powerful antibiotic in fresh food samples such as chicken, fish and vegetables. Scientists have also deciphered the mechanism by which a gene responsible for making disease-causing bacteria resistant to powerful antibacterial drugs can get transmitted to humans.

The new findings about the presence of bacteria resistant to colistin – an antibiotic of the last resort – in food samples, and insertion of resistant gene in bacteria called Klebsiella pneumoniae (which causes a range of infections in humans) were presented on Tuesday at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) which is underway at Madrid. Both the studies were presented by infectious diseases expert Abdul Ghafur of Apollo Cancer Institute, Chennai.

In the first study, the research group reported that the presence of colistin-resistant bacteria was very high in food samples (chicken, fish, meat, vegetables) collected from households, markets and fish and meat outlets. Out of 110 food samples collected in Chennai and analyzed, 46% grew colistin-resistant bacteria like E.coli, Enterobacter spp. and Klebsiella spp.

“The situation is extremely worrying. One possible source could be rampant use of colistin as a growth promoter in animal husbandry sector. Poultry litter is used as fertilizer in farms which leads to contamination in vegetables.,” observed Ghafur. More than 30 countries have already reported presence of colistin-resistant bacteria in raw food samples, but this is the first time scientists have searched for these bugs in fresh food samples in India.

The second study, also presented at the conference, deals with genetic mechanism of colistin resistance.

The widely studied gene responsible for colistin resistance in food bacteria as well as humans is known as ‘mobilized colistin resistance’ or mcr. But many colistin-resistant bacterial agents, particularly the bacteria Klebsiella do not possess this gene. They have abnormality in another gene called mgrB.

“We have discovered that colistin-resistant Klebsiella with mgr gene mutation can originate from food. Unlike mcr which is located in the plasmid part of bacteria and hence easily transmissible from food to humans, mgrB gene is located in the chromosome of the bacteria,” explained Ghafur. “If the gene is in the chromosome, then it should not easily spread among bacteria and so should be less dangerous. But we have found that presence of ‘jumping genes’ helps dissemination of mgrB gene mutation and colistin resistance from food bacteria to humans, creating bacteria resistant to the last line antibiotic-colistin.”

Ghafur collaborated with researchers from CMC Vellore and other experts for the two studies. Ghafur is the coordinator of Chennai declaration-a renowned initiative by medical societies in India to tackle antibiotic resistance and also a technical advisory member of National antibiotic policy.

“Presence of colistin-resistant bacteria does not affect edible quality of food, but we need to worry about them because once these resistant bacteria enter our gut and multiply they can spread resistance to other gut bacteria too,” he said while speaking to India Science Wire.

If food bacteria resistant to colistin but sensitive to other antibiotics enter gut, multiply and then mix up their genetic elements with gut bacteria resistant to all antibiotics except colistin, then it can give rise to bacteria resistant to all antibiotics including carbapenem and colistin. “This will make infections such as urinary tract infections or those caused due to surgery and chemotherapy untreatable. We call these bacteria ‘pan drug-resistant’-resistant to all antibiotics available in the modern medicine armamentarium’,” he added.

He suggested urgent steps like curbing the use of colistin in the veterinary sector. India imports about 200 tonnes of colistin every year, most of it from China. Interestingly, China has banned the use of colistin as growth promoter in animal feeds.

Twitter handle: @dineshcsharma

(India Science Wire)

Published on April 25, 2018

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.